Philip A. Laskawy Sells 2,604 Shares of Henry Schein, Inc. (NASDAQ:HSIC) Stock

Henry Schein, Inc. (NASDAQ:HSIC) Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Henry Schein Price Performance

HSIC opened at $69.39 on Friday. The stock has a 50-day moving average price of $74.82 and a 200-day moving average price of $72.60. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market cap of $8.62 billion, a PE ratio of 28.56, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same period last year, the firm posted $0.66 EPS. Henry Schein’s quarterly revenue was up 5.8% compared to the same quarter last year. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Henry Schein

Hedge funds have recently bought and sold shares of the business. Nuance Investments LLC raised its position in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after buying an additional 414,748 shares during the last quarter. Olstein Capital Management L.P. raised its position in Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after buying an additional 16,000 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in Henry Schein in the 3rd quarter worth about $515,000. Private Management Group Inc. increased its position in shares of Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock valued at $24,256,000 after purchasing an additional 18,882 shares during the last quarter. Finally, Equitable Trust Co. purchased a new stake in shares of Henry Schein during the 4th quarter valued at about $417,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Finally, UBS Group dropped their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.